COVID vaccine live updates: What you should know in South Florida on Wednesday, April 7 Michelle Marchante and Howard Cohen, The Miami Herald
Apr. 7 COVID-19 vaccine rules can be confusing in South Florida. Here s the latest news on where shots are available and who is eligible:
What s new today? A Hialeah walk-up COVID vaccine site goes from pop-up to open for two weeks at Babcock Park, 651 E. Fourth Ave. First shots only for now. Will convert to second doses later. Starting with Moderna through Sunday, April 11. Then Pfizer. Walk up site, no appointments necessary. FEMA pop-ups moving to Liberty City and Cutler Bay again this time for second doses only. These sites don t require an appointment and are currently at Allen Park Community Center at 1770 NE 162nd St. in North Miami Beach and at the Miami Springs Community Center at 1401 Westward Dr. through 5 p.m. Wednesday, April 7.
Herbert Wertheim College of Medicine ranked one of the most diverse medical schools in the nation
fiu.edu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiu.edu Daily Mail and Mail on Sunday newspapers.
New study points to novel drug target for treating COVID-19
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
Tampa Bay hospitals among the World s Best, Newsweek says - Tampa Bay Business Journal
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
Florida International University
Search
Scott R. MacKenzie Foundation awards $350,000 in support of two-year clinical trial
March 3, 2021 at 12:00am
Diana Azzam, a researcher in the Robert Stempel College of Public Health & Social Work, will collaborate with Cleveland Clinic Florida on a study to find new treatment options for cancer patients.
The research, funded by a $350,000 grant from the Scott R. MacKenzie Foundation, focuses on the clinical utility of drug sensitivity testing and genomic profiling to treat sarcomas, one of the most common types of aggressive, malignant tumors.
Azzam, assistant professor in the Department of Environmental Health Sciences, will test the efficacy of a series of clinically approved compounds on tumor tissue samples. The drugs she determines to be most effective on the patient’s tumor cells will be used to guide treatments in the clinic.